Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell, Marginal Zone × carfilzomib × Clear all

NCT03269552 2020-01-18

Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma

Phase 2 Terminated

4 enrolled 12 charts

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone